| Authors: |
Park J; Lunit, Seoul, Republic of Korea., Shin S; Lunit, Seoul, Republic of Korea., Hwang W; Lunit, Seoul, Republic of Korea., Keum S; Lunit, Seoul, Republic of Korea., Brattoli B; Lunit, Seoul, Republic of Korea., Rawson JH; Astrazeneca, Cambridge, United Kingdom., Lee T; Lunit, Seoul, Republic of Korea., Pereira S; Lunit, Seoul, Republic of Korea., Ahn CH; Lunit, Seoul, Republic of Korea., Senior MJT; Astrazeneca, Cambridge, United Kingdom., Qaiser T; Astrazeneca, Cambridge, United Kingdom., Kim S; Department of Pathology, Ajou University School of Medicine, Suwon, Republic of Korea., Kim H; Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Chung JH; Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Choi YL; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Bannister H; Astrazeneca, Cambridge, United Kingdom., Riboni-Verri E; Astrazeneca, Cambridge, United Kingdom., Ock CY; Lunit, Seoul, Republic of Korea., Hill RJ; Astrazeneca, Cambridge, United Kingdom., Ali S; Lunit, Seoul, Republic of Korea., Moore L; Astrazeneca, Cambridge, United Kingdom. |
